Glenmark Pharmaceuticals plans to buyback FCC Bonds aggregating USD 100 mn

Glenmark Pharmaceuticals is looking to buyback part of its FCC Bonds at repurchase price of 105% of the principal amount outstanding per FCC Bond up to an aggregate purchase price of U.S.$ 100 million plus accrued but unpaid interest.

MUFG Securities Asia and J. P. Morgan Securities are appointed as dealer managers, on behalf of the Company to purchase such FCC Bonds.

Powered by Capital Market - Live News